paladin's Recent Posts
Title ▼ Rating Company Posted on
Re: Revised target market, indications, market potential? ... and some numbers? 11 Resverlogix Corp. Jun 15, 2020 10:34AM
Re: Revised target market, indications, market potential? ... and some numbers? 3 Resverlogix Corp. Jun 15, 2020 02:42PM
Re: Revised target market, indications, market potential? ... and some numbers? 7 Resverlogix Corp. Jun 13, 2020 09:55AM
Re: Revised target market, indications, market potential? ... and some numbers? 3 Resverlogix Corp. Jun 13, 2020 11:27AM
Re: Revised target market, indications, market potential? ... and some numbers? 6 Resverlogix Corp. Jun 14, 2020 02:25AM
Re: Revenue Canada 3 Resverlogix Corp. Nov 15, 2019 08:45AM
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits 4 Resverlogix Corp. Jul 08, 2019 09:29AM
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits 5 Resverlogix Corp. Jul 08, 2019 09:33AM
Re: Resverlogix to Present at the European Society of Cardiology’s ESC Congress 2019 2 Resverlogix Corp. Aug 14, 2019 11:22AM
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019 1 Resverlogix Corp. Dec 02, 2019 09:08AM
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019 4 Resverlogix Corp. Dec 02, 2019 10:08AM
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers 8 Resverlogix Corp. Nov 02, 2020 07:06PM
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study 6 Resverlogix Corp. Jun 22, 2020 09:50AM
Re: Resverlogix Provides Update on BETonMACE Phase 3 Trial 1 Resverlogix Corp. Sep 16, 2019 09:07AM
Re: Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Dru 2 Resverlogix Corp. Nov 01, 2021 10:19AM
Re: Resverlogix Expands Phase 2b Clinical Trial for COVID-19 7 Resverlogix Corp. Feb 17, 2022 02:43PM
Re: Resverlogix Confirms Significant Corporate Advancement Establishing Apabetalone as Potential Blockbuster Combo Drug in High-risk Diabetics with CVD 4 Resverlogix Corp. Jan 13, 2020 09:24AM
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication 4 Resverlogix Corp. Mar 27, 2020 11:05AM
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication 4 Resverlogix Corp. Mar 27, 2020 02:11PM
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS 2 Resverlogix Corp. Jun 22, 2022 01:27PM